Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
2016;11:CD006683
It triggered "explosive" demand around the world and even led to a shortage of medicines at one point
Published Phase 2 data provides a timeline for GI adverse event duration: Phase Timeline Stomach Pain Severity Initial dose Weeks 1-2 Onset of GI symptoms mild to moderate cramping and nausea Dose escalation Weeks 2-8 Peak GI discomfort each dose increase can trigger a new wave of symptoms Stabilization Weeks 8-16 Symptoms begin to diminish as the body adapts to stable dosing Maintenance Weeks 16+ Most participants report significant GI symptom improvement or resolution The Phase 2 trial (48 weeks) confirmed that the majority of GI adverse events including stomach pain were concentrated in the dose-escalation period and attenuated over time
For the complete class of melanocortins under investigation, see also our Complete guide to peptides in France 2026.
US$ 20.84
US$ 22.38
US$ 29.21
US$ 26.02
US$ 29.96
US$ 20.43
US$ 22.27
US$ 21.07
